A Prospective Randomized Clinical Trial of Combination Sequential Treatment With Y Peginterferon Alfa-2b and ETV (Entecavir) in CHB (Chronic Hepatitis B) Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Adefovir; Entecavir; Granulocyte macrophage colony stimulating factor
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms ANCHOR
- 24 Oct 2017 Interim results (n=101) assessing virological supression, presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.
- 11 Aug 2016 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 11 Aug 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.